• Poster
  • P 064

Resistance analysis in a phase 2 clinical trial with the helicase-primase inhibitor Pritelivir in immunocompromised adults with Acyclovir resistant Herpes Simplex Virus (HSV) infection

Termin

Datum:
Zeit:
Redezeit:
Diskussionszeit:
Ort / Stream:
Clinical virology

Thema

  • Clinical virology